2023
DOI: 10.1039/d3nj01638b
|View full text |Cite
|
Sign up to set email alerts
|

Mimicry of sorafenib: novel diarylureas as VEGFR2 inhibitors and apoptosis inducers in breast cancer

Abstract: Thirteen diarylurea derivatives were designed and synthesized as sorafenib mimetics.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
references
References 45 publications
0
0
0
Order By: Relevance